A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
A 60-Year-Old Man with Weakness and Gait Dysfunction
JAMA Neurol 82:305-306, Jones,F.J.S.,et al, 2025
Clinicopathologic Conference, Anti-IgLON5 IgG-Associated Neurologic Disorder
NEJM 386:173-180, Case 1-2022, 2022
Hereditary Spastic Paraplegia:From Diagnosis to Emerging Therapeutic Approaches
Lancet Neurol 18:1136-1146, Shribman,S.,et al, 2019
Amyotrophic Lateral Sclerosis
NEJM 377:162-172, Brown, R.H.,et al, 2017
Neurodegenerative causes of death among retired National Football League Players
Neurol 79:1970-1974, Lehman, E.,et al, 2012
Spinal Muscular Atrophy
Lancet 371:2120-2133, Lunn,M.R. &Wang,C.H., 2008
What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008
Amyotrophic Lateral Sclerosis
Lancet 369:2031-2041, Mitchell,J.D. & Borasio,G.D., 2007
Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000
Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999
Motor Neuron Syndromes in Cancer Patients
Ann Neurol 41:722-730, 7031997., Forsyth,P.A.,et al, 1997
Motor Neuron Disease:A Paraneoplastic Process Associated with Anti-Hu Antibody and Small-Cell Lung Carcinoma
Ann Neurol 40:112-116, Verma,A.,et al, 1996
The Clinical Correlates of High-Titer IgG Anti-GM1 Antibodies
Ann Neurol 35:234-237, Kornberg,A.J.,et al, 1994
Intravenous Immunoglobulin Trtm in Pts with Motor Neuron Syndromes Assoc with Anti-GM Antibodies:A Contrld Study
Neurol 44:429-432, Azulay,J-P.,et al, 1994
Motor Neuron Diseases and Amyotrophic Lateral Sclerosis:GM1 Antibodies and Paraproteinemia
Neurol 43:418-420, Sanders,K.A.,et al, 1993
Amyotrophic Lateral Sclerosis and Lymphoma:Bone Marroe Examination and Other Diagnostic Tests
Neurol 42:1101-1102, Rowland,L.P.,et al, 1992
Anti-Hu-Associated Pareneoplastic Encephalomyelitis/Sensory Neuronopathy
Medicine 71:59-72, Dalmau,J.,et al, 1992
The Spectrum of Neurologic Disease Associated with Anti-GM1 Antibodies
Neurol 40:1067-1072, Sadiq,S.A.,et al, 1990
Lower Motor Neuron Disease in a Patient with Autoantibodies Against Gangliosides GM1 and GD1b:Improvement with Immunotherapy
Neurol 40:842-844, Shy,M.E.,et al, 1990
Polyclonal IgM Anti-GM1 Ganglioside Antibody in Patients with Motor Neuron Disease and Variants
Ann Neurol 27:558-563, Salazar-Grueso,E.F.,et al, 1990
Anti-GM1 IgM Antibodies in Motor Neuron Disease and Neuropathy
Neurol 40:1747-1750, Nobile-Orazio,E.,et al, 1990
The Remote Effects of Cancer on the Nervous System
in Neurol Manif of Systemic Dis, W. B. Saunders, Co, Phila, Neurologic Clinics 7:579-603, Dropcho,E.J., 1989
Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Progressive Pontobulbar Palsy With Deafness
Arch Neurol 38:186-190, Brucher,J.M.,et al, 1981
Infantile Neuronal Degeneration Masquerading as Werdnig-Hoffmann Disease
Ann Neurol 8:317-324, Steiman,G.S.,et al, 1980
Epidemiology of Motor-Neuron Diseases
NEJM 288:1047, Bobwick,A.R.,et al, 1973